Drug Shortage Report for SANDOZ TRAVOPROST
| Report ID | 102663 |
| Drug Identification Number | 02413167 |
| Brand name | SANDOZ TRAVOPROST |
| Common or Proper name | TRAVOPROST |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TRAVOPROST |
| Strength(s) | 0.004% |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ml |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2019-12-09 |
| Estimated end date | 2020-01-31 |
| Actual end date | 2020-01-10 |
| Shortage status | Resolved |
| Updated date | 2020-02-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-02-15 | French | Compare |
| v3 | 2020-02-15 | English | Compare |
| v2 | 2020-01-08 | French | Compare |
| v1 | 2020-01-08 | English | Compare |
Showing 1 to 4 of 4